Autocrine and paracrine regulatory functions of platelet serotonin

References

• Whitaker-Azmitia PM. The discovery of serotonin and its role in neuroscience. Neuropsychopharmacol: Official Publication Am Coll Neuropsychopharmacol. 1999;21(2 Suppl):2S–8S. doi:10.1016/S0893-133X(99)00031-7.
   PubMed Web of Science ®Google Scholar
• Hickman AB, Klein DC, Dyda F. Melatonin biosynthesis: the structure of serotonin N-acetyltransferase at 2.5 a resolution suggests a catalytic mechanism. Mol Cell. 1999;3(1):23–32. doi:10.1016/S1097-2765(00)80171-9.
   PubMed Web of Science ®Google Scholar
• Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med. 2009;60:355–366. doi:10.1146/annurev.med.60.042307.110802.
   PubMed Web of Science ®Google Scholar
• Berumen LC, Rodriguez A, Miledi R, Garcia-Alcocer G. Serotonin receptors in hippocampus. Sci World J. 2012;2012:823493. doi:10.1100/2012/823493.
   Google Scholar
• Carhart-Harris RL, Nutt DJ. Serotonin and brain function: a tale of two receptors. J Psychopharmacology. 2017;31(9):1091–1120. doi:10.1177/0269881117725915.
   PubMed Web of Science ®Google Scholar
• Spohn SN, Mawe GM. Non-conventional features of peripheral serotonin signalling - the gut and beyond. Nat Rev Gastroenterol Hepatol. 2017;14(7):412–420. doi:10.1038/nrgastro.2017.51.
   PubMed Web of Science ®Google Scholar
• Walther DJ, Bader M. A unique central tryptophan hydroxylase isoform. Biochem Pharmacol. 2003;66(9):1673–1680. doi:10.1016/S0006-2952(03)00556-2.
   PubMed Web of Science ®Google Scholar
• Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP. International union of pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev. 1994;46(2):157–203.
   PubMed Web of Science ®Google Scholar
• Paulmann N, Grohmann M, Voigt JP, Bert B, Vowinckel J, Bader M, Skelin M, Jevsek M, Fink H, Rupnik M and others. Intracellular serotonin modulates insulin secretion from pancreatic beta-cells by protein serotonylation. PLoS Biol. 2009;7(10):e1000229. doi:10.1371/journal.pbio.1000229.
   PubMed Web of Science ®Google Scholar
• Kim H, Toyofuku Y, Lynn FC, Chak E, Uchida T, Mizukami H, Fujitani Y, Kawamori R, Miyatsuka T, Kosaka Y and others. Serotonin regulates pancreatic beta cell mass during pregnancy. Nat Med. 2010;16(7):804–808. doi:10.1038/nm.2173.
   PubMed Web of Science ®Google Scholar
• Nowak JZ, Szymanska B, Zawilska JB, Bialek B. Hydroxyindole-O-methyltransferase activity in ocular and brain structures of rabbit and hen. J Pineal Res. 1993;15(1):35–42. doi:10.1111/j.1600-079X.1993.tb00507.x.
   PubMed Web of Science ®Google Scholar
• Keszthelyi D, Troost FJ, Masclee AA. Understanding the role of tryptophan and serotonin metabolism in gastrointestinal function. Neurogastroenterol Motility: off J Eur Gastrointest Motil Soc. 2009;21(12):1239–1249. doi:10.1111/j.1365-2982.2009.01370.x.
   PubMed Web of Science ®Google Scholar
• Mossner R, Lesch KP. Role of serotonin in the immune system and in neuroimmune interactions. Brain Behav Immun. 1998;12(4):249–271. doi:10.1006/brbi.1998.0532.
   PubMed Web of Science ®Google Scholar
• Joy T, Walsh G, Tokmakejian S, Van Uum SH. Increase of urinary 5-hydroxyindoleacetic acid excretion but not serum chromogranin a following over-the-counter 5-hydroxytryptophan intake. Can J Gastroenterol. 2008;22(1):49–53. doi:10.1155/2008/472159.
   PubMedGoogle Scholar
• Walther DJ, Peter JU, Winter S, Holtje M, Paulmann N, Grohmann M, Vowinckel J, Alamo-Bethencourt V, Wilhelm CS, Ahnert-Hilger G and others. Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release. Cell. 2003;115(7):851–862. doi:10.1016/S0092-8674(03)01014-6.
   PubMed Web of Science ®Google Scholar
• Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP. Allelic variation of human serotonin transporter gene expression. J Neurochem. 1996;66(6):2621–2624. doi:10.1046/j.1471-4159.1996.66062621.x.
   PubMed Web of Science ®Google Scholar
• Stober G, Heils A, Lesch KP. Serotonin transporter gene polymorphism and affective disorder. Lancet. 1996;347(9011):1340–1341. doi:10.1016/S0140-6736(96)90993-9.
   PubMedGoogle Scholar
• Murphy DL, Lerner A, Rudnick G, Lesch KP. Serotonin transporter: gene, genetic disorders, and pharmacogenetics. Mol Interv. 2004;4(2):109–123. doi:10.1124/mi.4.2.8.
   PubMedGoogle Scholar
• Murphy DL, Lesch KP. Targeting the murine serotonin transporter: insights into human neurobiology. Nat Rev Neurosci. 2008;9(2):85–96. doi:10.1038/nrn2284.
   PubMed Web of Science ®Google Scholar
• Mercado CP, Kilic F. Molecular mechanisms of SERT in platelets: regulation of plasma serotonin levels. Mol Interv. 2010;10(4):231–241. doi:10.1124/mi.10.4.6.
   PubMedGoogle Scholar
• Wolf K, Braun A, Haining EJ, Tseng YL, Kraft P, Schuhmann MK, Gotru SK, Chen W, Hermanns HM, Stoll G and others. Partially Defective Store Operated Calcium Entry and Hem(ITAM) signaling in platelets of serotonin transporter deficient mice. PloS One. 2016;11(1):e0147664. doi:10.1371/journal.pone.0147664.
   PubMed Web of Science ®Google Scholar
• Turetta L, Bazzan E, Bertagno K, Musacchio E, Deana R. Role of Ca(2+) and protein kinase C in the serotonin (5-HT) transport in human platelets. Cell Calcium. 2002;31(5):235–244. doi:10.1016/S0143-4160(02)00052-0.
   PubMed Web of Science ®Google Scholar
• Ramamoorthy S, Giovanetti E, Qian Y, Blakely RD. Phosphorylation and regulation of antidepressant-sensitive serotonin transporters. J Biol Chem. 1998;273(4):2458–2466. doi:10.1074/jbc.273.4.2458.
   PubMed Web of Science ®Google Scholar
• Qian Y, Galli A, Ramamoorthy S, Risso S, DeFelice LJ, Blakely RD. Protein kinase C activation regulates human serotonin transporters in HEK-293 cells via altered cell surface expression. J Neuroscience: Official Journal Soc Neurosci. 1997;17(1):45–57. doi:10.1523/JNEUROSCI.17-01-00045.1997.
   PubMed Web of Science ®Google Scholar
• Anderson GM, Horne WC. Activators of protein kinase C decrease serotonin transport in human platelets. Biochimica Et Biophysica Acta. 1992;1137(3):331–337. doi:10.1016/0167-4889(92)90154-4.
   PubMedGoogle Scholar
• Myers CL, Lazo JS, Pitt BR. Translocation of protein kinase C is associated with inhibition of 5-HT uptake by cultured endothelial cells. Am J Physiol. 1989;257(4 Pt 1):L253–258.
   PubMedGoogle Scholar
• Pavanetto M, Zarpellon A, Borgo C, Donella-Deana A, Deana R. Regulation of serotonin transport in human platelets by tyrosine kinase Syk. Cell Physiol Biochem: Int J Exp Cell Phys Biochem Pharmacol. 2011;27(2):139–148. doi:10.1159/000325216.
   PubMed Web of Science ®Google Scholar
• Carneiro AM, Cook EH, Murphy DL, Blakely RD. Interactions between integrin alphaIIbbeta3 and the serotonin transporter regulate serotonin transport and platelet aggregation in mice and humans. J Clin Invest. 2008;118(4):1544–1552. doi:10.1172/JCI33374.
   PubMed Web of Science ®Google Scholar
• Varga-Szabo D, Braun A, Nieswandt B. Calcium signaling in platelets. J Thrombosis Haemostasis: JTH. 2009;7(7):1057–1066. doi:10.1111/j.1538-7836.2009.03455.x.
   Web of Science ®Google Scholar
• Baumgartner HR, Born GV. Effects of 5-hydroxytryptamine on platelet aggregation. Nature. 1968;218(5137):137–141. doi:10.1038/218137a0.
   PubMed Web of Science ®Google Scholar
• Dale GL. Coated-platelets: an emerging component of the procoagulant response. J Thrombosis Haemostasis: JTH. 2005;3(10):2185–2192. doi:10.1111/j.1538-7836.2005.01274.x.
   Web of Science ®Google Scholar
• Dale GL, Friese P, Batar P, Hamilton SF, Reed GL, Jackson KW, Clemetson KJ, Alberio L. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature. 2002;415(6868):175–179. doi:10.1038/415175a.
   PubMed Web of Science ®Google Scholar
• Vaswani M, Linda FK, Ramesh S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry. 2003;27(1):85–102. doi:10.1016/S0278-5846(02)00338-X.
   PubMed Web of Science ®Google Scholar
• Stahl SM. Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects. J Affect Disord. 1998;51(3):215–235. doi:10.1016/S0165-0327(98)00221-3.
   PubMed Web of Science ®Google Scholar
• Tatsumi M, Groshan K, Blakely RD, Richelson E. Pharmacological profile of antidepressants and related compounds at human monoamine transporters. Eur J Pharmacol. 1997;340(2–3):249–258. doi:10.1016/S0014-2999(97)01393-9.
   PubMed Web of Science ®Google Scholar
• Maurer-Spurej E. Serotonin reuptake inhibitors and cardiovascular diseases: a platelet connection. Cell Mol Life Sci: CMLS. 2005;62(2):159–170. doi:10.1007/s00018-004-4262-1.
   PubMed Web of Science ®Google Scholar
• Noordam R, Aarts N, Leening MJ, Tiemeier H, Franco OH, Hofman A, Stricker BH, Visser LE. Use of antidepressants and the risk of myocardial infarction in middle-aged and older adults: a matched case-control study. Eur J Clin Pharmacol. 2016;72(2):211–218. doi:10.1007/s00228-015-1972-2.
   PubMed Web of Science ®Google Scholar
• Feighner JP. Mechanism of action of antidepressant medications. J Clin Psychiatry. 1999;60(Suppl 4):4–11. discussion 12-13.
   PubMed Web of Science ®Google Scholar
• Pacher P, Kecskemeti V. Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? Curr Pharm Des. 2004;10(20):2463–2475. doi:10.2174/1381612043383872.
   PubMed Web of Science ®Google Scholar
• Lopez-Munoz F, Alamo C. Monoaminergic neurotransmission: the history of the discovery of antidepressants from 1950s until today. Curr Pharm Des. 2009;15(14):1563–1586. doi:10.2174/138161209788168001.
   PubMed Web of Science ®Google Scholar
• Kessler RC, Aguilar-Gaxiola S, Alonso J, Chatterji S, Lee S, Ormel J, Ustun TB, Wang PS. The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiologia E Psichiatria Sociale. 2009;18(1):23–33. doi:10.1017/S1121189X00001421.
   PubMed Web of Science ®Google Scholar
• Ramachandraih CT, Subramanyam N, Bar KJ, Baker G, Yeragani VK. Antidepressants: from MAOIs to SSRIs and more. Indian J Psychiatry. 2011;53(2):180–182. doi:10.4103/0019-5545.82567.
   PubMedGoogle Scholar
• Menys VC, Smith CC, Lewins P, Farmer RD, Noble MI. Platelet 5-hydroxytryptamine is decreased in a preliminary group of depressed patients receiving the 5-hydroxytryptamine re-uptake inhibiting drug fluoxetine. Clin Sci (Lond). 1996;91(1):87–92. doi:10.1042/cs0910087.
   PubMed Web of Science ®Google Scholar
• Laghrissi-Thode F, Wagner WR, Pollock BG, Johnson PC, Finkel MS. Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry. 1997;42(4):290–295. doi:10.1016/S0006-3223(96)00345-9.
   PubMed Web of Science ®Google Scholar
• Pollock BG, Laghrissi-Thode F, Wagner WR. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. J Clin Psychopharmacol. 2000;20(2):137–140. doi:10.1097/00004714-200004000-00004.
   PubMed Web of Science ®Google Scholar
• Serebruany VL, Gurbel PA, O’Connor CM. Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. Pharmacoll Res. 2001;43(5):453–462. doi:10.1006/phrs.2001.0817.
   PubMed Web of Science ®Google Scholar
• Parkin L, Balkwill A, Sweetland S, Reeves GK, Green J, Beral V, Million Women Study C. Antidepressants, depression, and venous thromboembolism risk: large prospective study of UK women. J Am Heart Assoc. 2017;6:5. doi:10.1161/JAHA.116.005316.
   Web of Science ®Google Scholar
• Anglin R, Yuan Y, Moayyedi P, Tse F, Armstrong D, Leontiadis GI. Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis. Am J Gastroenterol. 2014;109(6):811–819. doi:10.1038/ajg.2014.82.
   PubMed Web of Science ®Google Scholar
• Jiang HY, Chen HZ, Hu XJ, Yu ZH, Yang W, Deng M, Zhang YH, Ruan B. Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal bleeding: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2015;13(1):42–50 e43. doi:10.1016/j.cgh.2014.06.021.
   PubMed Web of Science ®Google Scholar
• Hankey GJ. Selective serotonin reuptake inhibitors and risk of cerebral bleeding. Stroke. 2014;45(7):1917–1918. doi:10.1161/STROKEAHA.114.005844.
   PubMed Web of Science ®Google Scholar
• Weinrieb RM, Auriacombe M, Lynch KG, Chang KM, Lewis JD. A critical review of selective serotonin reuptake inhibitor-associated bleeding: balancing the risk of treating hepatitis C-infected patients. J Clin Psychiat. 2003;64(12):1502–1510. doi:10.4088/JCP.v64n1215.
   PubMed Web of Science ®Google Scholar
• Ziu E, Mercado CP, Li Y, Singh P, Ahmed BA, Freyaldenhoven S, Lensing S, Ware J, Kilic F. Down-regulation of the serotonin transporter in hyperreactive platelets counteracts the pro-thrombotic effect of serotonin. J Mol Cell Cardiol. 2012;52(5):1112–1121. doi:10.1016/j.yjmcc.2012.02.004.
   PubMed Web of Science ®Google Scholar
• Wester P, Dietrich WD, Prado R, Watson BD, Globus MY. Serotonin release into plasma during common carotid artery thrombosis in rats. Stroke. 1992;23(6):870–875. doi:10.1161/01.STR.23.6.870.
   PubMed Web of Science ®Google Scholar
• Przyklenk K, Frelinger AL, 3rd, Linden MD, Whittaker P, Li Y, Barnard MR, Adams J, Morgan M, Al-Shamma H, Michelson AD. Targeted inhibition of the serotonin 5HT2A receptor improves coronary patency in an in vivo model of recurrent thrombosis. J Thrombosis Haemostasis: JTH. 2010;8(2):331–340. doi:10.1111/j.1538-7836.2009.03693.x.
   Web of Science ®Google Scholar
• Nieswandt B, Kleinschnitz C, Stoll G. Ischaemic stroke: a thrombo-inflammatory disease? J Physiol. 2011;589(17):4115–4123. doi:10.1113/jphysiol.2011.212886.
   PubMed Web of Science ®Google Scholar
• Mead GE, Hsieh CF, Lee R, Kutlubaev MA, Claxton A, Hankey GJ, Hackett ML. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev. 2012;11:CD009286.
   PubMedGoogle Scholar
• Siepmann T, Penzlin AI, Kepplinger J, Illigens BM, Weidner K, Reichmann H, Barlinn K. Selective serotonin reuptake inhibitors to improve outcome in acute ischemic stroke: possible mechanisms and clinical evidence. Brain Behav. 2015;5(10):e00373. doi:10.1002/brb3.373.
   PubMed Web of Science ®Google Scholar
• Espinera AR, Ogle ME, Gu X, Wei L. Citalopram enhances neurovascular regeneration and sensorimotor functional recovery after ischemic stroke in mice. Neuroscience. 2013;247:1–11. doi:10.1016/j.neuroscience.2013.04.011.
   PubMed Web of Science ®Google Scholar
• Pakala R, Willerson JT, Benedict CR. Mitogenic effect of serotonin on vascular endothelial-cells. Circulation. 1994;90(4):1919–1926. doi:10.1161/01.CIR.90.4.1919.
   PubMed Web of Science ®Google Scholar
• Pakala R, Benedict CR. Effect of serotonin and thromboxane A2 on endothelial cell proliferation: effect of specific receptor antagonists. J Lab Clin Med. 1998;131(6):527–537. doi:10.1016/S0022-2143(98)90061-0.
   PubMed Web of Science ®Google Scholar
• Nemecek GM, Coughlin SR, Handley DA, Moskowitz MA. Stimulation of aortic smooth muscle cell mitogenesis by serotonin. Proc Natl Acad Sci U S A. 1986;83(3):674–678. doi:10.1073/pnas.83.3.674.
   PubMed Web of Science ®Google Scholar
• Lang PA, Contaldo C, Georgiev P, El-Badry AM, Recher M, Kurrer M, Cervantes-Barragan L, Ludewig B, Calzascia T, Bolinger B and others. Aggravation of viral hepatitis by platelet-derived serotonin. Nat Med. 2008;14(7):756–761. doi:10.1038/nm1780.
   PubMed Web of Science ®Google Scholar
• Li Y, Hadden C, Cooper A, Ahmed A, Wu H, Lupashin VV, Mayeux PR, Kilic F. Sepsis-induced elevation in plasma serotonin facilitates endothelial hyperpermeability. Sci Rep. 2016;6:22747. doi:10.1038/srep22747.
   PubMed Web of Science ®Google Scholar
• Cloutier N, Pare A, Farndale RW, Schumacher HR, Nigrovic PA, Lacroix S, Boilard E. Platelets can enhance vascular permeability. Blood. 2012;120(6):1334–1343. doi:10.1182/blood-2012-02-413047.
   PubMed Web of Science ®Google Scholar
• Lesurtel M, Graf R, Aleil B, Walther DJ, Tian Y, Jochum W, Gachet C, Bader M, Clavien PA. Platelet-derived serotonin mediates liver regeneration. Science. 2006;312(5770):104–107. doi:10.1126/science.1123842.
   PubMed Web of Science ®Google Scholar
• Nocito A, Georgiev P, Dahm F, Jochum W, Bader M, Graf R, Clavien PA. Platelets and platelet-derived serotonin promote tissue repair after normothermic hepatic ischemia in mice. Hepatology. 2007;45(2):369–376. doi:10.1002/hep.21516.
   PubMed Web of Science ®Google Scholar
• Matondo RB, Punt C, Homberg J, Toussaint MJ, Kisjes R, Korporaal SJ, Akkerman JW, Cuppen E, de Bruin A. Deletion of the serotonin transporter in rats disturbs serotonin homeostasis without impairing liver regeneration. Am J Physiol Gastrointest Liver Physiol. 2009;296(4):G963–968. doi:10.1152/ajpgi.90709.2008.
   PubMed Web of Science ®Google Scholar
• Wilson MS, Wynn TA. Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunol. 2009;2(2):103–121. doi:10.1038/mi.2008.85.
   PubMed Web of Science ®Google Scholar
• Almeida I, Faria R, Vita P, Vasconcelos C. Systemic sclerosis refractory disease: from the skin to the heart. Autoimmun Rev. 2011;10(11):693–701. doi:10.1016/j.autrev.2011.04.025.
   PubMed Web of Science ®Google Scholar
• Oates JA, Melmon K, Sjoerdsma A, Gillespie L, Mason DT. Release of a Kinin Peptide in the Carcinoid Syndrome. Lancet. 1964;1(7332):514–517. doi:10.1016/S0140-6736(64)92907-1.
   PubMedGoogle Scholar
• Chen C, Han X, Fan F, Liu Y, Wang T, Wang J, Hu P, Ma A, Tian H. Serotonin drives the activation of pulmonary artery adventitial fibroblasts and TGF-beta1/Smad3-mediated fibrotic responses through 5-HT(2A) receptors. Mol Cell Biochem. 2014;397(1–2):267–276. doi:10.1007/s11010-014-2194-0.
   PubMed Web of Science ®Google Scholar
• Welsh DJ, Harnett M, MacLean M, Peacock AJ. Proliferation and signaling in fibroblasts: role of 5-hydroxytryptamine2A receptor and transporter. Am J Respir Crit Care Med. 2004;170(3):252–259. doi:10.1164/rccm.200302-264OC.
   PubMed Web of Science ®Google Scholar
• Johnson DE, Georgieff MK. Pulmonary neuroendocrine cells. Their secretory products and their potential roles in health and chronic lung disease in infancy. Am Rev Respir Dis. 1989;140(6):1807–1812. doi:10.1164/ajrccm/140.6.1807.
   PubMed Web of Science ®Google Scholar
• Dees C, Akhmetshina A, Zerr P, Reich N, Palumbo K, Horn A, Jungel A, Beyer C, Kronke G, Zwerina J and others. Platelet-derived serotonin links vascular disease and tissue fibrosis. J Exp Med. 2011;208(5):961–972. doi:10.1084/jem.20101629.
   PubMed Web of Science ®Google Scholar
• Davis RB, Meeker WR, Mc QD. Immediate effects of intravenous endotoxin on serotonin concentrations and blood platelets. Circ Res. 1960;8:234–239. doi:10.1161/01.RES.8.1.234.
   PubMed Web of Science ®Google Scholar
• Fuchs BA, Campbell KS, Munson AE. Norepinephrine and serotonin content of the murine spleen: its relationship to lymphocyte beta-adrenergic receptor density and the humoral immune response in vivo and in vitro. Cell Immunol. 1988;117(2):339–351. doi:10.1016/0008-8749(88)90123-2.
   PubMed Web of Science ®Google Scholar
• Gershon RK. A disquisition on suppressor T cells. Transplant Rev. 1975;26:170–185.
   PubMed Web of Science ®Google Scholar
• Sibella-Arguelles C. The proliferation of human T lymphoblastic cells induced by 5-HT1B receptors activation is regulated by 5-HT-moduline. C R Acad Sci III. 2001;324(4):365–372. doi:10.1016/S0764-4469(00)01300-7.
   PubMed Web of Science ®Google Scholar
• Gobin V, Van Steendam K, Denys D, Deforce D. Selective serotonin reuptake inhibitors as a novel class of immunosuppressants. Int Immunopharmacol. 2014;20(1):148–156. doi:10.1016/j.intimp.2014.02.030.
   PubMed Web of Science ®Google Scholar
• Iken K, Chheng S, Fargin A, Goulet AC, Kouassi E. Serotonin upregulates mitogen-stimulated B lymphocyte proliferation through 5-HT1A receptors. Cell Immunol. 1995;163(1):1–9. doi:10.1006/cimm.1995.1092.
   PubMed Web of Science ®Google Scholar
• Duerschmied D, Suidan GL, Demers M, Herr N, Carbo C, Brill A, Cifuni SM, Mauler M, Cicko S, Bader M and others. Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice. Blood. 2013;121(6):1008–1015. doi:10.1182/blood-2012-06-437392.
   PubMed Web of Science ®Google Scholar
• Cloutier N, Allaeys I, Marcoux G, Machlus KR, Mailhot B, Zufferey A, Levesque T, Becker Y, Tessandier N, Melki I and others. Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration. Proc Natl Acad Sci U S A. 2018;115(7):E1550–E1559. doi:10.1073/pnas.1720553115.
   PubMed Web of Science ®Google Scholar
• Durk T, Duerschmied D, Muller T, Grimm M, Reuter S, Vieira RP, Ayata K, Cicko S, Sorichter S, Walther DJ and others. Production of serotonin by tryptophan hydroxylase 1 and release via platelets contribute to allergic airway inflammation. Am J Respir Crit Care Med. 2013;187(5):476–485. doi:10.1164/rccm.201208-1440OC.
   PubMed Web of Science ®Google Scholar
• Lechin F, Van Der Dijs B, Orozco B, Lechin M, Lechin AE. Increased levels of free serotonin in plasma of symptomatic asthmatic patients. Ann Allergy Asthma Immunol. 1996;77(3):245–253. doi:10.1016/S1081-1206(10)63263-2.
   PubMed Web of Science ®Google Scholar
• Lechin F, van der Dijs B, Orozco B, Jara H, Rada I, Lechin ME, Lechin AE. The serotonin uptake-enhancing drug tianeptine suppresses asthmatic symptoms in children: a double-blind, crossover, placebo-controlled study. J Clin Pharmacol. 1998;38(10):918–925. doi:10.1002/j.1552-4604.1998.tb04387.x.
   PubMed Web of Science ®Google Scholar
• Lechin F, van der Dijs B, Orozco B, Jara H, Rada I, Lechin ME, Lechin AE. Neuropharmacologic treatment of bronchial asthma with the antidepressant tianeptine: a double-blind, crossover placebo-controlled study. Clin Pharmacol Ther. 1998;64(2):223–232. doi:10.1016/S0009-9236(98)90156-4.
   PubMed Web of Science ®Google Scholar
• Lechin F, Van Der Dijs B, Lechin AE. Treatment of bronchial asthma with tianeptine. Methods Find Exp Clin Pharmacol. 2004;26(9):697–701. doi:10.1358/mf.2004.26.9.872567.
   PubMedGoogle Scholar
• Mammadova-Bach E, Mangin P, Lanza F, Gachet C. Platelets in cancer. From basic research to therapeutic implications. Hamostaseologie. 2015;35(4):325–336. doi:10.5482/hamo-14-11-0065.
   PubMed Web of Science ®Google Scholar
• Sarrouilhe D, Clarhaut J, Defamie N, Mesnil M. Serotonin and cancer: what is the link? Curr Mol Med. 2015;15(1):62–77. doi:10.2174/1566524015666150114113411.
   PubMed Web of Science ®Google Scholar
• Skolnik G, Bagge U, Blomqvist G, Djarv L, Ahlman H. The role of calcium channels and serotonin (5-HT2) receptors for tumour cell lodgement in the liver. Clin Exp Metastasis. 1989;7(2):169–174. doi:10.1007/BF01787021.
   PubMed Web of Science ®Google Scholar
• Ho-Tin-Noe B, Goerge T, Cifuni SM, Duerschmied D, Wagner DD. Platelet granule secretion continuously prevents intratumor hemorrhage. Cancer Res. 2008;68(16):6851–6858. doi:10.1158/0008-5472.CAN-08-0718.
   PubMed Web of Science ®Google Scholar
• Demers M, Ho-Tin-Noe B, Schatzberg D, Yang JJ, Wagner DD. Increased efficacy of breast cancer chemotherapy in thrombocytopenic mice. Cancer Res. 2011;71(5):1540–1549. doi:10.1158/0008-5472.CAN-10-2038.
   PubMed Web of Science ®Google Scholar
• Padickakudy R, Pereyra D, Offensperger F, Jonas P, Oehlberger L, Schwarz C, Haegele S, Assinger A, Brostjan C, Gruenberger T, and others. Bivalent role of intra-platelet serotonin in liver regeneration and tumor recurrence in humans. J Hepatol. 2017;67(6):1243–1252. doi:10.1016/j.jhep.2017.08.009.
   PubMed Web of Science ®Google Scholar
• Chan HL, Chiu WC, Chen VC, Huang KY, Wang TN, Lee Y, McIntyre RS, Hsu TC, Lee CT, Tzang BS. SSRIs associated with decreased risk of hepatocellular carcinoma: a population-based case-control study. Psychooncology. 2018;27(1):187–192. doi:10.1002/pon.4493.
   PubMed Web of Science ®Google Scholar
• Christensen DK, Armaiz-Pena GN, Ramirez E, Matsuo K, Zimmerman B, Zand B, Shinn E, Goodheart MJ, Bender D, Thaker PH, and others. SSRI use and clinical outcomes in epithelial ovarian cancer. Oncotarget. 2016;7(22):33179–33191. doi:10.18632/oncotarget.8891.
   PubMedGoogle Scholar
• Boursi B, Lurie I, Haynes K, Mamtani R, Yang YX. Chronic therapy with selective serotonin reuptake inhibitors and survival in newly diagnosed cancer patients. Eur J Cancer Care (Engl). 2018;27:1. doi:10.1111/ecc.12666.
   Web of Science ®Google Scholar